GSK reaffirmed its commitment to London as its listing location and announced the opening of a new global headquarters in central London.
GSK Plc (LSE:GSK) plans to stay loyal to London, according to comments from chief executive Emma Walmsley.
It comes amidst a run of UK-listed companies large and small are exiting, with through takeovers transfers to other exchanges or simply going
Walmsley, speaking at the Time CEO Summit, commented that GSK is "unequivocally, 100 per cent committed" to its London listing, despite the company conducting only 3% of its business in the UK.
"We have nine sites. We’ve got factories from Montrose to Worthing. We have 11,000 people and we have 300 apprentices every single year," Walmsley emphasized, underlining the company’s substantial operations in the UK.
Walmsley also announced that GSK will be opening its new global headquarters in central London next month.
"We’re just about to open, next month, our new global headquarters in central London because this can be a great magnet and attraction for talent," she added.
